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Introduction
Endocytosis is critical for the ability of cells to adapt to changes 
in the environment. One of its primary functions is to attenuate 
intracellular signaling after stimulation, through the down-
regulation of plasma membrane receptors. Conversely, intra-
cellular signaling also regulates endocytosis. The endocytosis 
of receptors often relies on their own signaling activity or that 
of a close partner, such as for receptor tyrosine kinases or 
G protein–coupled receptors (Sorkin and von Zastrow, 2009). 
However, intracellular signaling also influences the endocytosis 
of transporters (Miranda and Sorkin, 2007; Argenzio et al., 2011; 
Vina-Vilaseca et al., 2011), but because transporters lack intrinsic 
signaling activity, this regulation remains poorly understood.
The yeast Saccharomyces cerevisiae is a powerful model 
system for studying transporter endocytosis in response to 
nutritional changes (Haguenauer-Tsapis and André, 2004). 
Numerous examples of nutrient-induced down-regulation of 
transporters were described since the early studies on yeast 
genetics and physiology. In particular, amino acid and sugar 
transporters were shown to undergo “catabolite inactivation” 
(Holzer, 1976; Grenson, 1983; Haguenauer-Tsapis and André, 
2004), in which transporter activity was thought to be inacti-
vated in response to a nutritional change, but which were later 
revealed as the first examples of signal-induced transporter 
endocytosis (Hein et al., 1995; Medintz et al., 1996; Horak 
and Wolf, 1997; Lucero and Lagunas, 1997; Haguenauer-Tsapis 
and André, 2004).
S. cerevisiae preferentially uses glucose for growth, and 
glucose-starved yeast cells rapidly adapt upon exposure to 
glucose by remodeling their enzymatic content. For instance, 
glucose causes the degradation of enzymes involved in the 
metabolism of alternate carbon sources. In addition, glucose 
also induces the endocytosis of various sugar transporters 
(Horák, 2003) and of Jen1 (Paiva et al., 2002), a monocarboxylate 
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tein through a switch in post-translational modifications.
A molecular switch on an arrestin-like protein relays 
glucose signaling to transporter endocytosis
Michel Becuwe,1 Neide Vieira,2 David Lara,3 Jéssica Gomes-Rezende,2 Carina Soares-Cunha,2 Margarida Casal,2 
Rosine Haguenauer-Tsapis,1 Olivier Vincent,3 Sandra Paiva,2 and Sébastien Léon1
1Institut Jacques Monod, Centre National de la Recherche Scientifique, UMR 7592, Université Paris Diderot, Sorbonne Paris Cité, F-75205 Paris, France
2Department of Biology, Molecular and Environmental Biology Centre (CBMA), University of Minho, Campus de Gualtar, 4710-057 Braga, Portugal
3Instituto de Investigaciones Biomédicas CSIC-UAM, Arturo Duperier, 4, 28029 Madrid, Spain
© 2012 Becuwe et al. This article is distributed under the terms of an Attribution–
Noncommercial–Share Alike–No Mirror Sites license for the first six months after the pub-
lication date (see http://www.rupress.org/terms). After six months it is available under a 
Creative Commons License (Attribution–Noncommercial–Share Alike 3.0 Unported license, 
as described at http://creativecommons.org/licenses/by-nc-sa/3.0/).
T
H
E
J
O
U
R
N
A
L
O
F
C
E
L
L
B
IO
L
O
G
Y
JCB • VOLUME 196 • NUMBER 2 • 2012 248
establish that Rod1 is a crucial player in glucose-induced 
transporter endocytosis, and provide the first molecular in-
sights into the mechanism of arrestin-related protein activa-
tion in response to intracellular signaling.
Results
The arrestin-like protein Rod1 is required 
for the glucose-induced endocytosis of the 
lactate transporter Jen1
Previous work has shown that the endocytosis of a given 
transporter can be mediated by various signals through the 
involvement of different arrestin-related proteins, suggesting 
that they are involved in signal-specific endocytosis (Lin 
et al., 2008; Nikko and Pelham, 2009). To gain insight into 
how an extracellular signal regulates endocytosis, we studied 
the glucose-induced endocytosis of the lactate transporter, 
Jen1, as a model, and first aimed to identify whether a yeast 
arrestin-related protein is involved in this process. We mea-
sured the down-regulation of lactate transport activity, i.e., 
Jen1 internalization away from the plasma membrane, after 
glucose addition in various mutants in which the genes encoding 
arrestin-related proteins were disrupted. Specifically, Jen1 
was not subjected to glucose-induced inactivation in rod1, 
whereas mutants for other arrestin-related genes were not 
affected (Fig. 1 A and Fig. S1 A). Consistent with this obser-
vation, the glucose-induced trafficking of Jen1-GFP was 
abnormal in the rod1 mutant, in which Jen1 was stably local-
ized at the plasma membrane (Fig. 1 B), and its degradation in 
response to glucose was strongly affected (Fig. 1 C). Rod1 
was specifically involved in the regulation of glucose-induced 
endocytosis because neither the glucose-mediated repression 
of the invertase gene (SUC2) nor the glucose-induced degra-
dation of fructose-1,6-bisphosphatase (Fbp1) were affected 
in the rod1 mutant (Fig. S1, B and C). Likewise, Rod1 was 
not required for Jen1 endocytosis in response to a glucose-
unrelated signal, such as cycloheximide, which stimulates the 
endocytosis of several transporters (Lin et al., 2008; Nikko 
and Pelham, 2009) including Jen1 (Fig. S1 D). We conclude 
that Rod1 is not a general regulator of Jen1 endocytosis but 
rather participates in its “catabolite inactivation” by glucose.
The glucose-induced endocytosis of Jen1 involves its 
ubiquitylation by Rsp5 (Paiva et al., 2009), the sole Nedd4-like 
ubiquitin ligase of yeast, which was previously shown to inter-
act with Rod1 (Andoh et al., 2002). To establish an eventual 
contribution of Rod1 in the Rsp5-mediated ubiquitylation of 
Jen1, we assessed Jen1 ubiquitylation in response to glucose in 
a strain devoid of Rod1. We used an endocytic mutant, end3, 
which is known to accumulate transporters in a ubiquitylated 
state, to improve the detection of ubiquitylated conjugates. As 
shown in Fig. 1 D, the glucose-induced ubiquitylation of Jen1 
occurred several minutes after glucose addition in the end3 
strain, whereas it was strongly diminished and delayed when the 
ROD1 gene was further deleted (Fig. 1 D). These results demon-
strate that Rod1 is required for the rapid and efficient ubiquity-
lation of Jen1 in response to glucose, which may explain the 
endocytosis defects observed in the rod1 mutant.
transporter of the SLC16/MCT family (Casal et al., 2008). The 
endocytosis of transporters requires their ubiquitylation by 
Rsp5, a ubiquitin ligase of the Nedd4 family that harbors 
several members in higher eukaryotes, some of which also par-
ticipate in endocytosis (Rotin and Kumar, 2009). Therefore, the 
number of possible Rsp5 substrate is tremendous, leading to the 
question of how these transporters are specifically recognized 
by Rsp5, and how the timeliness of the ubiquitylation reaction 
is ensured. Proteins of the Nedd4/Rsp5 family are known to 
interact, through their WW domains, with proteins harboring 
a PY motif (usually, a “PPxY” sequence). However, a very lim-
ited number of membrane proteins harbor this motif. Instead, it 
has become clear that the interaction between Rsp5 and the 
transporters occurs through so-called adaptor proteins that 
generally display at least one PY motif (Polo and Di Fiore, 
2008; Léon and Haguenauer-Tsapis, 2009).
In particular, several yeast proteins with homologies to 
arrestins (arrestin-related trafficking adaptors, or ARTs, also 
coined “alpha-arrestins”) were proposed to recruit Rsp5 to 
transporters in response to changes in the environment (Lin 
et al., 2008; Polo and Di Fiore, 2008; Nikko and Pelham, 2009). 
Yeast arrestin-related proteins display human homologues, 
named ARRDC (arrestin domain-containing), which also act as 
adaptors of Nedd4-like enzymes (Draheim et al., 2010; Nabhan 
et al., 2010) and are evolutionary related to -arrestins from 
higher eukaryotes, which participate in endocytosis and signaling 
(DeWire et al., 2007; Alvarez, 2008). Although the discovery of 
these arrestin-related proteins has provided a molecular basis 
explaining how Rsp5 interacts with and ubiquitylates trans-
porters, it does not fully explain how transporter ubiquitylation 
is regulated in a timely manner with respect to the presence of 
extracellular signals. Indeed, phosphorylation of the metal 
transporter Smf1 was shown to promote the recruitment of the 
yeast arrestin-related protein Ecm21/Art2 (Nikko et al., 2008), 
but although this is required for Smf1 endocytosis it did not 
appear to be the trigger, suggesting the involvement of an addi-
tional regulatory step. Importantly, yeast arrestin-related proteins 
were described to regulate endocytosis in a signal-specific 
rather than transporter-specific manner (Lin et al., 2008; Nikko 
and Pelham, 2009). This raised the possibility that they become 
activated in response to a specific signal. However, the exis-
tence of such an activation mechanism remains unknown.
In this paper, we identified the arrestin-related protein 
Rod1, also named Art4, as an essential component of the 
glucose-induced endocytosis of Jen1, the lactate transporter. 
We show that Rod1 is a direct target of the glucose-signaling 
pathway composed of the Snf1 kinase, the yeast homologue of 
5-AMP-activated kinase (AMPK), and the protein phospha-
tase 1 (PP1). As such, Rod1 phosphorylation status is regu-
lated by glucose availability, which consequently modulates 
its activity. In particular, we show that the glucose-induced 
dephosphorylation of Rod1 promotes its ubiquitylation, a 
modification that is essential for Jen1 endocytosis. Moreover, 
we demonstrate that this cross talk between dephosphoryla-
tion and ubiquitylation of Rod1 is coordinated by a phospho-
dependent interaction of Rod1 with yeast 14-3-3 proteins, 
which inhibits Rod1 ubiquitylation. Altogether, our findings 
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Rod1 phosphorylation and ubiquitylation 
are dynamically regulated  
by glucose availability
Rod1 is therefore a major actor in the glucose-induced endo-
cytosis of Jen1, consistent with its previous involvement in the 
glucose-induced endocytosis of the high-affinity glucose trans-
porter Hxt6 (Nikko and Pelham, 2009). We then sought to in-
vestigate how Rod1 function in endocytosis is specifically 
regulated by glucose availability. When cells were cultured 
overnight in glucose medium, the HA epitope-tagged Rod1 
migrated primarily as a diffuse band on SDS-PAGE (Fig. 2 A, 
lane 1). This was due to Rod1 phosphorylation because phos-
phatase treatment of protein extracts led to a single band that 
displayed a faster migration. Rod1 phosphorylation was strongly 
enhanced when cells were grown in lactate medium (lane 2) 
but was rapidly lost upon glucose addition (lanes 3 and 4), 
The WW domains of Rsp5 interact with (L/P)PxY 
sequences (named “PY” motifs; Rotin and Kumar, 2009). 
Rod1, like most arrestin-related proteins, displays two such 
PY motifs, and a point mutation in both PPxY sequences result-
ing in PPxA (Rod1-PYm) abolished the interaction with Rsp5 
WW domains in vitro (Fig. S1 E). Although the Rod1-PYm 
construct was expressed at similar levels to the wild-type (WT) 
protein (Fig. S1 E), the mutant protein was unable to restore 
Jen1 endocytosis in a rod1 mutant background, suggesting an 
essential function for the Rod1/Rsp5 interaction in this process 
(Fig. 1 E). This is consistent with the role of arrestin-related 
proteins in assisting transporter ubiquitylation by Rsp5 (Lin 
et al., 2008; Nikko et al., 2008; Hatakeyama et al., 2010). How-
ever, because we have not observed a direct interaction between 
Rod1 and Jen1, we cannot exclude the possibility that Rod1 acts 
more indirectly on Jen1 ubiquitylation.
Figure 1. The arrestin-related protein Rod1 is involved in the glucose-induced endocytosis of the lactate transporter, Jen1. (A) WT and rod1 cells were 
grown in lactate medium, and 14C-labeled lactate transport activity was followed over time after glucose addition. A representative experiment of more 
than three repetitions is shown. The values represent the mean ± SEM of triplicate measurements. (B) Cells in which Jen1 is tagged with GFP at the chro-
mosomal locus were grown in lactate medium, and Jen1-GFP subcellular localization was followed after glucose addition for the indicated times in 
WT and rod1 strains. Bar, 5 µm. (C) Total protein extracts from a similar experiment as in B were prepared at the indicated times after glucose addition and 
immunoblotted with the indicated antibodies. (D, top) A plasmid-encoded, galactose-inducible Jen1-GFP-His6 construct was expressed in end3 (control) 
and end3 rod1 cells. Total protein extracts were prepared at several time points after glucose addition and immunoblotted with anti-GFP or anti-PGK 
(loading control) antibodies. Arrowheads indicate ubiquitylated Jen1 species. (Bottom) Jen1-GFP-His6 was purified under denaturing conditions by 
Ni-based chromatography 10 min after glucose addition. The eluates were loaded twice and incubated with anti-GFP or anti-ubiquitin (P4D1) antibodies. 
(E) A rod1 strain expressing Jen1-GFP tagged at the chromosomal locus was transformed with an empty plasmid (Ø) or plasmid-encoded Rod1-3HA or 
Rod1-PYm-3HA, and the cells were imaged after 4 h of growth on lactate medium, and 30 min after the addition of glucose. Bar, 5 µm.
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Figure 2. Dynamic modifications of Rod1 by phosphorylation and ubiquitylation are regulated by glucose availability. (A) A WT strain expressing a 
plasmid-encoded Rod1-3HA was grown overnight in glucose medium (exponential phase), then 4 h in lactate medium, before glucose was added for the 
indicated times. Total protein extracts were either treated or untreated with calf intestinal phosphatase (CIP) and immunoblotted with anti-HA and anti-PGK 
antibodies. (B) A WT strain expressing plasmid-encoded Rod1-3HA and 6xHis-tagged ubiquitin was grown for 4 h in lactate medium before glucose was 
added for 10 min. 6xHis-tagged ubiquitin conjugates were purified under denaturing conditions by Ni-based chromatography. The lysates (Lys.) and 
eluates (El.) were immunoblotted with an anti-ubiquitin antibody, and with an anti-HA antibody to detect Rod1. (C) Strains expressing a plasmid-encoded 
Rod1-3HA or a variant mutated on both PPxY motifs (Rod1-PYm-3HA) were grown as in B. Total protein extracts were immunoblotted with an anti-HA 
antibody. A nonspecific, cross-reactive band was used as internal loading control. P/Ub refers to the molecular weight of phosphorylated or ubiquitylated 
Rod1, respectively. (D, top) Representation of Rod1 primary sequence. The numbers below show the amino acid boundaries of the predicted arrestin-
related domains (“Arrestin_N”/PF00339 and “Arrestin_C”/PF02752) as determined by Pfam. The position of the Rod1 lysines that were mutated to raise 
the Rod1-KR-3HA construct (below) is displayed above the scheme. (Bottom) A strain expressing a plasmid-encoded Rod1-3HA or a mutant form in which 
the four lysines depicted in the scheme above are mutated to arginine (Rod1-KR-3HA) were grown as in A. Total protein extracts were immunoblotted with 
anti-HA and anti-PGK antibodies. P/Ub refers to the molecular weight of phosphorylated or ubiquitylated Rod1, respectively. (E) A rod1 strain in which 
Jen1 is tagged with GFP at the chromosomal locus was transformed with an empty plasmid (ø), or plasmids encoding Rod1-3HA or Rod1-KR-3HA, and 
grown for 3 h in lactate medium before glucose was added for the indicated times. Total protein extracts were immunoblotted with an anti-GFP antibody. 
Band intensities were quantified using ImageJ and the GFP*/Jen1-GFP ratio is plotted over time. (F) Jen1-GFP subcellular localization was followed in the 
same strains as in E grown in similar conditions. Bar, 5 µm.
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(Fig. 3 C) and localized predominantly to intracellular com-
partments, including the vacuole, rather than the plasma mem-
brane (Fig. 3 D). Strikingly, the additional deletion of ROD1 in 
this mutant restored lactate transport activity, as well as Jen1 
stabilization and plasma membrane localization (Fig. 3, B–D), 
showing that the defects observed in the absence of Snf1 were 
due to a constitutive, Rod1-dependent endocytosis, even in the 
absence of glucose.
Reg1, a regulatory subunit of protein 
phosphatase 1 (PP1), interacts with Rod1 
and is required for Rod1 ubiquitylation  
and activation
A yeast two-hybrid screen using Rod1 as the bait led to the 
identification of the C-terminal half of Reg1 (Fig. 3 E), a regula-
tory subunit of the protein phosphatase PP1 that dephosphory-
lates and thus inactivates Snf1 in the presence of glucose 
(Hedbacker and Carlson, 2008). This interaction involves the 
N-terminal region of Rod1 harboring the arrestin domain. To 
evaluate a putative role for PP1 in Rod1 regulation, we assessed 
the Rod1 phosphorylation status in a reg1 strain. Indeed, Rod1 
was strongly phosphorylated in this strain (Fig. 3 F), even in 
glucose-grown cells, and the rapid dephosphorylation observed 
in WT cells during the lactate–glucose transition was strongly 
diminished (compare lane 3 with lane 6). Although we cannot 
exclude that PP1 regulates Rod1 phosphorylation through the 
regulation of Snf1 activity, the physical interaction between 
Rod1 and Reg1 as well as the rapid kinetics of Rod1 dephos-
phorylation in response to glucose strongly suggest that Rod1 is a 
new direct target of PP1. Importantly, Rod1 was not ubiquity-
lated in response to glucose in the reg1 mutant (Fig. 3 F, lane 9), 
further confirming that Rod1 dephosphorylation is required for 
its ubiquitylation. Therefore, Rod1 activation requires Reg1. 
Consistent with this, the glucose-induced endocytosis of Jen1 was 
impaired in the reg1 mutant (Fig. 3, G and H; and Fig. S3 A), 
as reported previously for other sugar transporters (Jiang et al., 
2000b; Horák, 2003; Mayordomo et al., 2003). Altogether, 
these results show that Rod1 ubiquitylation and activity are 
modulated by its phosphorylation status through the opposing 
activities of the Snf1 kinase and the PP1 phosphatase. Note-
worthy, we confirmed that the Snf1/PP1 pathway was the only 
glucose-signaling pathway involved in the glucose-induced 
endocytosis of Jen1 (Fig. S3, B–G). Indeed, glucose-mediated 
Jen1 down-regulation was normal in cells deficient for the 
glucose sensors Snf3 and Rgt2 and the glucose receptor Gpr1 
(Fig. S3, H and I).
A phosphorylation-dependent interaction  
of Rod1 with 14-3-3 proteins regulates 
Rod1 ubiquitylation
To better understand the molecular basis by which Rod1 de-
phosphorylation controls its ubiquitylation, we investigated the 
contribution of Rod1 phosphorylation on its interaction with 
Rsp5. However, coimmunoprecipitation experiments revealed 
that Rod1 interacted with Rsp5 under all growth conditions 
(Fig. 4 A), indicating that Rod1 phosphorylation status does not 
alter its ability to interact with Rsp5. An alternative explanation 
revealing that Rod1 phosphorylation is controlled by glucose 
availability in the culture medium.
This paper also revealed that exposure to glucose induced 
an additional post-translational modification on Rod1, which was 
insensitive to phosphatase treatment (Fig. 2 A, lanes 7 and 8). 
A common feature of Rsp5 adaptor proteins is their propensity 
to be ubiquitylated by Rsp5, as described for several yeast 
arrestin-related proteins (Kee et al., 2006; Lin et al., 2008; 
Hatakeyama et al., 2010; Herrador et al., 2010) including Rod1 
(Andoh et al., 2002). As shown in Fig. 2 B, Rod1 ubiquitylation 
was indeed most prominent during the lactate–glucose tran-
sition, and was dependent on its interaction with Rsp5, as in-
dicated by the inability of the Rod1-PYm point mutant to 
be ubiquitylated (Fig. 2 C). The use of this mutant also con-
firmed that Rod1 ubiquitylation accounted for the observed 
phosphatase-insensitive modification mentioned above. There-
fore, Rod1 dephosphorylation in response to glucose is con-
comitant with its ubiquitylation by Rsp5.
To determine whether this modification is important for 
Rod1 function, we aimed at identifying the lysine residue tar-
geted for ubiquitylation. Using a lysine-less Rod1 construct, in 
which 48 lysines are mutated to arginine, and various chimeras 
(Fig. S2), we mapped the ubiquitylated site(s) to a 33-residue 
region (aa 235–267) located in the predicted “Arrestin_C” 
domain and that contains four lysines (Fig. 2 D). This mutant 
protein (Rod1-KR) was expressed at similar levels to the 
WT protein, but was not functional as determined by its inability 
to complement the rod1 mutant for the glucose-induced 
Jen1 degradation and vacuolar targeting (Fig. 2, E and F), 
indicating an essential role of Rod1 ubiquitylation in its func-
tion in endocytosis.
Loss of Rod1 phosphorylation leads to its 
constitutive ubiquitylation and activation
The sudden ubiquitylation of Rod1 in response to glucose and 
its importance for Jen1 endocytosis prompted us to study how 
this modification is regulated at the molecular level. We first 
set out to determine the eventual contribution of Rod1 phos-
phorylation in this process. Rod1 is a target of the Snf1 kinase 
(Shinoda and Kikuchi, 2007), the yeast homologue of AMPK, 
which is a crucial component of nutrient sensing and carbon 
metabolism regulation in eukaryotes (Hedbacker and Carlson, 
2008). We observed that in the snf1 mutant, Rod1 was indeed 
unphosphorylated (Fig. 3 A, lanes 5 and 6), but importantly, it 
was constitutively ubiquitylated regardless of the presence of 
glucose, as determined by the appearance of a phosphatase-
insensitive band (lanes 7 and 8) whose presence depended on 
the interaction of Rod1 with Rsp5 (lane 9) and that were identi-
fied as Rod1-ubiquitin conjugates (Fig. 3 A, right). This sug-
gested that the lack of Rod1 phosphorylation promotes its 
ubiquitylation. Because the Rod1 migration profile in the snf1 
mutant mimics that observed at the lactate–glucose transition 
during which Rod1 is activated, we expressed Jen1-GFP in a 
strain devoid of Snf1 to study its endocytosis. However, in this 
mutant, very little lactate transport activity was measured after 
induction (Fig. 3 B). Although Jen1-GFP was expressed, it was 
rapidly degraded in this strain in the course of its synthesis 
JCB • VOLUME 196 • NUMBER 2 • 2012 252
Figure 3. The Snf1/PP1 glucose-signaling pathway regulates Rod1 activation and Jen1 endocytosis. (A, left) WT and snf1 cells expressing plasmid-
encoded Rod1-3HA or Rod1-PYm-3HA were grown in glucose overnight and then 4 h in lactate medium. Crude extracts were prepared, treated with 
phosphatase where indicated, and immunoblotted with the indicated antibodies. The asterisk indicates ubiquitylated Rod1 as determined by the absence 
of this band in cells expressing Rod1-PYm (lane 9). (Right) snf1 cells expressing plasmid-encoded Rod1-3HA and 6xHis-tagged ubiquitin were grown 
overnight in glucose-containing medium (exponential phase). 6xHis-tagged ubiquitin conjugates were purified under denaturing conditions by Ni-based 
chromatography. The lysates (Lys.) and eluates (El.) were immunoblotted with an anti-ubiquitin antibody, and with an anti-HA antibody to detect Rod1. 
(B) The snf1 mutant is unable to grow on alternate sugars such as galactose or nonfermentable carbon sources, but the additional deletion of MIG1, 
encoding a Snf1-regulated transcriptional repressor, allows growth on galactose (Vallier and Carlson, 1994). Transport activity of 14C-labeled lactate was 
therefore assayed in the snf1 mig1 and snf1 mig1 rod1 strains transformed with a galactose-inducible Jen1-GFP-His6 construct after 2 h of growth 
in galactose medium. A representative experiment of three repetitions is shown. The values represent the mean ± SEM of triplicate measurements. 
(C) Crude extracts were prepared from the strains described in B. Crude extracts were prepared at the indicated times and immunoblotted with anti-GFP and 
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which this ubiquitylation promptly reacts to a change in nutrient 
availability remained unknown. Our results demonstrate that the 
yeast arrestin-related protein Rod1 relays intracellular signaling 
to transporter ubiquitylation and endocytosis.
Indeed, we established that Rod1 is a new direct target of 
both the Snf1 kinase and the PP1 phosphatase, Glc7/Reg1—
both of which play an essential role in the regulation of carbon 
source utilization and metabolism (Gancedo, 2008). Rod1 be-
comes rapidly activated in response to glucose replenishment, 
and acts as a downstream effector of the Snf1/PP1 pathway to 
mediate the catabolite inactivation of transporters for nonglu-
cose carbon sources such as Jen1, providing a novel molecular 
basis for the regulation of transporter endocytosis by intracel-
lular signaling. So far, the Snf1/PP1 signaling pathway was 
mostly documented for its role in transcriptional regulation in 
response to glucose (Gancedo, 2008). Snf1 modulates gene 
expression upon glucose depletion through the activation of 
the transcriptional activators Cat8 and Adr1, and inactivation 
of the Mig1 transcriptional repressor, while PP1 inactivates 
Snf1 and therefore allows adaptation to glucose medium. In-
terestingly, JEN1 promoter activity is itself regulated by Snf1, 
likely through the regulation of Mig1 and Cat8 (Bojunga and 
Entian, 1999; Lodi et al., 2002). Our results thus illustrate an 
integrated physiological response to glucose fluctuations 
where the same actors coordinate transcriptional and post-
translational regulations (Fig. 5).
We also uncovered a new example for the regulation 
of ubiquitylation by substrate dephosphorylation. Cross talks 
between various post-translational modifications have been 
described (Hunter, 2007), notably for substrates of F-box– 
containing E3 ligases that are ubiquitylated in a phosphoryla-
tion-dependent manner. In contrast, PP1-mediated dephosphory-
lation of Rod1 promotes its ubiquitylation and activation in 
response to a nutritional change. Rod1 ubiquitylation appears 
essential for Jen1 endocytosis, although the precise role of this 
modification on Rod1 function remains to be elucidated. The 
ubiquitylation of another arrestin-related protein, Art1, is also 
essential for its function in endocytosis; however, its ubiqui-
tylation appears constitutive in the conditions tested (Lin 
et al., 2008), whereas Rod1 ubiquitylation is induced by glu-
cose and may therefore provide an additional step for its regula-
tion. The signal-dependent ubiquitylation of arrestin-related 
proteins has been described in filamentous fungi (Herranz 
et al., 2005; Hervás-Aguilar et al., 2010) and is reminiscent 
of -arrestin ubiquitylation in mammalian cells in response to 
agonist treatment (DeWire et al., 2007); however, the precise 
mechanism by which this occurs is still unknown. Our findings are 
therefore likely to open new avenues toward understanding the 
to the coupling between Rod1 dephosphorylation and its ubiq-
uitylation came from the identification of Bmh1, one of the two 
redundant 14-3-3 proteins in yeast (with Bmh2), as a candidate 
in the yeast two-hybrid screen using Rod1 as a bait. 14-3-3 pro-
teins are a family of conserved eukaryotic proteins involved 
in many cellular functions, including signaling pathways, 
and often interact with their partners in a phosphorylation-
dependent manner (Bridges and Moorhead, 2005). To confirm 
this interaction in vivo, we first performed a GST pull-down 
using a GST-Bmh2 construct expressed in WT cells coexpress-
ing Rod1-3HA. This confirmed that indeed, when cells are 
grown overnight in glucose medium, Rod1 was able to interact 
with Bmh2 (Fig. 4 B). Previous reports have shown that 14-3-3 
proteins interact with Reg1 (Mayordomo et al., 2003; Dombek 
et al., 2004); however, the interaction between Rod1 and Bmh2 
did not depend on the presence of Reg1 because Rod1 and 
Bmh2 were still able to interact in a reg1 deletion mutant 
(Fig. 4 B). Given that Rod1 phosphorylation depends on glu-
cose availability, we assessed the dynamics of the interaction 
between Rod1 and Bmh2 in various conditions. As shown in 
Fig. 4 C, Rod1 strongly associated with Bmh2 when the cells 
were grown in lactate medium, but this interaction vanished in 
response to glucose, when Rod1 is dephosphorylated. Similarly, 
in the snf1 mutant, Rod1 failed to interact with Bmh2 (Fig. 4 D). 
This confirms that the Snf1-dependent phosphorylation of Rod1 
tunes its interaction with the 14-3-3 proteins.
To determine the role of the 14-3-3 proteins on Rod1 
ubiquitylation, we assessed its post-translational modifications 
in the bmh1 bmh2 double mutant (Roberts et al., 1997). In 
this mutant, Rod1 ubiquitylation was constitutive, regardless of 
the carbon source provided to the cells and of its phosphoryla-
tion status (Fig. 4, E and F), showing that in this mutant, these 
two modifications are uncoupled. These data indicate that the 
interaction between Rod1 and 14-3-3 coordinates Rod1 ubiqui-
tylation in response to glucose availability.
Discussion
The endocytosis of yeast transporters has been described for 
many years to be triggered by nutritional changes, especially in 
the case of carbon sources transporters (Horák, 2003). Notably, 
the involvement of signaling pathway components in the regula-
tion of the endocytosis of carbon sources transporters has been 
observed (Jiang et al., 2000a,b; Horak et al., 2002; Mayordomo 
et al., 2003), but there were no details as to how this regulation 
operates at the molecular level. Also, although it is known that 
the signal-induced ubiquitylation of transporters leads to their 
endocytosis (Haguenauer-Tsapis and André, 2004), the way by 
anti-PGK antibodies. GFP* indicates the size of a proteolytic fragment indicative of Jen1-GFP degradation in the vacuole. Band intensities were quantified 
using ImageJ and the Jen1-GFP/GFP* ratio is plotted over time. (D) Jen1-GFP localization was followed in strains as in B after 2 h of induction. (E) A yeast 
two-hybrid screen using full-length Rod1 as the bait led to the identification of the C-terminal region of Reg1, a PP1 regulatory subunit. Rsp5 was used 
as a positive control. Average -galactosidase activity values (Miller units) for each combination are presented. (F) WT and reg1 strains expressing 
plasmid-encoded Rod1-3HA were grown as indicated and total protein extracts were treated with phosphatase when indicated, and immunoblotted with 
the indicated antibodies. (G) WT and reg1 strains in which Jen1 is tagged with GFP at the chromosomal locus were grown for 4 h in lactate medium, and 
Jen1-GFP subcellular localization was followed at the indicated time after glucose addition by fluorescence microscopy. Bar, 5 µm. (H) The same strains as 
in G were grown in similar conditions. Samples were collected at the indicated times after glucose treatments and total protein extracts were immunoblotted 
with anti-GFP antibodies. GFP* indicates the size of a proteolytic fragment indicative of Jen1-GFP degradation in the vacuole.
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that could be regulated in a similar manner as Rod1, but in 
response to nitrogen signaling.
An important question that should now be addressed in 
more detail is the subcellular localization of yeast arrestin-
related proteins, and the compartment at which they perform 
their function. It was initially proposed that they are recruited 
and act at the plasma membrane, and at least a partial localiza-
tion at this compartment was observed for several of them (Lin 
et al., 2008; Herrador et al., 2010; O’Donnell et al., 2010). The 
fact that Rod1 is required for the glucose-induced ubiquitylation 
of Jen1 in an endocytic mutant (end3; Fig. 1 D) suggests that 
Jen1 ubiquitylation indeed occurs at the plasma membrane. 
Rod1 is mainly a cytosolic protein, and although we did not 
observe a significant enrichment of Rod1 at the plasma mem-
brane in response to glucose, this localization is still compatible 
with a transient function at this compartment (unpublished 
data). We also observed that a pool of Rod1 localizes to punc-
tate structures (unpublished data). This is reminiscent of the 
observations concerning Ldb19/Art1, Aly1/Art6, or Aly2/Art3 
that also localize to internal structures of an endosomal/
trans-Golgi nature (Lin et al., 2008; O’Donnell et al., 2010). 
This localization does not preclude a direct involvement of yeast 
regulation of the signal-induced ubiquitylation of arrestin-
related proteins.
We further unraveled the involvement of 14-3-3 proteins 
in the coordination of this molecular switch by protecting phos-
phorylated Rod1 from ubiquitylation (Fig. 5). 14-3-3 proteins 
were reported to bind phosphorylated Nedd4-2, which inhibits 
its interaction with the sodium channel ENaC, and consequently 
impairs ENaC ubiquitylation and endocytosis (Bhalla et al., 
2005; Yang and Kumar, 2010; Chandran et al., 2011). We un-
covered a new level of regulation by showing that 14-3-3 pro-
teins can also regulate an intramolecular cross talk between 
phosphorylation and ubiquitylation on a ubiquitin ligase adap-
tor protein. Strikingly, a proteomic study identified most of 
the yeast arrestin-related proteins as phospho-dependent interac-
tants of 14-3-3 proteins, suggestive of their more general involve-
ment in the regulation of arrestin-related proteins (Kakiuchi 
et al., 2007). Among them, Aly2/Art3 regulates the endocytosis 
of the basic amino acid transporter Dip5 (Hatakeyama et al., 
2010), and is phosphorylated by Npr1 (O’Donnell et al., 2010), a 
protein kinase controlled by nitrogen limitation known to 
regulate endocytosis (De Craene et al., 2001; Haguenauer-
Tsapis and André, 2004). Aly2 is therefore a likely candidate 
Figure 4. Rod1 ubiquitylation is regulated 
by a phospho-dependent binding to 14-3-3 
proteins. (A) WT cells expressing a plasmid-
encoded Rod1-GFP construct were trans-
formed with an empty plasmid or a plasmid 
encoding 3HA-Rps5. Immunoprecipitation of 
3HA-Rsp5 was performed from cells grown 
as indicated. The input (Lys) and immuno-
precipitated (IP) fractions were immunoblotted 
with the indicated antibodies. (B) WT and 
reg1 cells expressing Rod1-3HA tagged at 
the chromosomal locus were transformed with 
a plasmid encoding GST-Bmh2 or GST alone 
as a control. GST pull-downs were performed 
from cells harvested after overnight growth 
in glucose medium (exponential phase). The 
input (Lys) and pull-down (PD) fractions were 
immunoblotted with the indicated antibodies. 
Asterisk indicates a nonspecific band that 
sometimes cross-reacted with the anti-GST anti-
body. (C) WT cells in which Rod1 is tagged 
with GFP at the chromosomal locus were trans-
formed with a plasmid encoding GST-Bmh2 or 
GST alone. GST pull-downs were performed 
from cells grown as indicated, and the input 
(Lys) and pull-down (PD) fractions were immuno-
blotted with the indicated antibodies. (D) WT 
or snf1 strains in which Rod1 is tagged with 
GFP at the chromosomal locus were trans-
formed with a plasmid encoding GST-Bmh2 or 
GST alone and grown overnight (exponential 
phase) in glucose medium. GST pull-downs 
were performed, and input (Lys) and pull-
down (PD) fractions were immunoblotted with 
the indicated antibodies. Asterisk indicates a 
nonspecific band that sometimes cross-reacted 
with the anti-GST antibody. (E) WT or bmh1 
bmh2 strains expressing a plasmid-encoded 
Rod1-GFP were grown as indicated. Total pro-
tein extracts were treated with phosphatase 
when indicated to better visualize ubiquity-
lation, and immunoblotted with the indicated 
antibodies. (F) bmh1 bmh2 strains express-
ing a plasmid-encoded Rod1-GFP (WT or PYm) 
were grown as indicated and treated as in E.
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is also responsible for the signal-induced ubiquitylation 
of SLCs.
Among these ARRDC proteins, TXNIP/VDUP-1, which 
regulates insulin sensitivity and energy balance in mice 
(Chutkow et al., 2010), is particularly relevant to our paper 
because both TXNIP and Rod1 regulate glucose transport activ-
ity (Parikh et al., 2007; Lin et al., 2008; Nikko and Pelham, 
2009). Cancer cells are known to display an enhanced glyco-
lytic activity and impaired oxidative phosphorylation even under 
aerobic conditions (Warburg effect), similarly to S. cerevisiae 
when grown in the presence of glucose (Diaz-Ruiz et al., 2011). 
The high-affinity glucose transporters (GLUT1 and GLUT3) 
are overexpressed in several cancer cell lines, in which they 
are thought to allow an increase in glycolysis rate and thus pro-
mote tumor progression (Macheda et al., 2005). Inhibition of 
GLUT transporters has been used to impair the growth of 
tumor cells in vitro and in vivo (Cao et al., 2007; Young et al., 
2011), and so was the inhibition of lactate transporters in vivo 
(Sonveaux et al., 2008). Therefore, addressing the potential 
involvement of ARRDC proteins in the regulation of carbon 
sources transporter, and understanding the molecular basis of 
their activation in this context, might be critical to the strategies 
of metabolic therapies (Nijsten and van Dam, 2009).
Materials and methods
Yeast strains, transformation, and growth conditions
Strains are listed and detailed in Table S1. They are derivatives of the 
∑1278b background for the bmh1bmh2 strains, W303 for snf1 mig1, 
snf1 mig1 rod1, and snf3 rgt2 gpr1 mth1 strains, and BY4741/2 
background for all other strains. Yeast two-hybrid screening was performed 
using the CTY10.5d and TAT7 strains. Yeast was transformed by standard 
lithium acetate/polyethylene glycol procedure. Cells were grown in yeast 
extract/peptone/glucose (YPD) rich medium, or in synthetic complete (SC) 
medium containing 2% (wt/vol) Glc, or 0.5% (vol/vol) Na-lactate, pH 5.0 
(Sigma-Aldrich).
Cells were grown overnight in SC-Glc, harvested in early exponential 
phase (A600: 0.3), resuspended in SC-lactate, and grown for 4 h (A600: 0.6) 
before the addition of glucose (2% wt/vol, final concentration).
For galactose induction, cells were precultured in SC-Glc medium 
and grown overnight to early exponential phase (A600: 0.3) in SC me-
dium containing 2% raffinose (wt/vol) and 0.02% Glc (wt/vol) to initiate 
growth. Galactose was then added at a final concentration of 2% (wt/vol) 
and cells were grown for the indicated times. Chase/endocytosis was 
arrestin-related proteins in the signal-induced ubiquitylation 
of transporters at intracellular compartments. Indeed, it has 
been proposed that Rsp5 ubiquitylates the reductive iron trans-
porter (Fet3/Ftr1 complex) at the level of endosomes (Strochlic 
et al., 2008). Hence, we cannot exclude that Rod1 acts, at least 
partially, at intracellular compartments (Fig. 5). Noteworthy, 
-arrestins and the arrestin domain-containing protein ARRDC3 
were proposed to regulate ubiquitylation of G protein–coupled 
receptor by Nedd4-like E3 ligases at endosomes (Bhandari 
et al., 2007; Shenoy et al., 2008; Nabhan et al., 2010), and it 
may very well be that some yeast arrestin-related proteins act 
likewise toward certain cargoes.
In mammalian cells, the endocytosis of several solute 
carriers (SLCs) is known to be influenced by various signal-
ing pathways. Recently, EGF treatment of HeLa cells was 
reported to lead to an increase in the ubiquitylation of many 
SLCs, such as members of the monocarboxylate transporter/
SLC16 family, which belong to the same family as Jen1 
(Argenzio et al., 2011). Interestingly, in this paper SLC3A2 
was reported to be modified by K63-linked ubiquitin chains, 
a type of ubiquitylation performed by several members of 
the Nedd4/Rsp5 ubiquitin ligase family (Kee et al., 2005; 
Kim et al., 2011; Maspero et al., 2011), suggesting a possible 
involvement of Nedd4 in the EGF-induced ubiquitylation 
of SLCs. Other SLCs, such as the dopamine transporter DAT/
SLC6A3 and the cationic amino acid transporter CAT-1/
SLC7A1 undergo a signal-induced, Nedd4-dependent ubiq-
uitylation (Sorkina et al., 2006; Vina-Vilaseca et al., 2011). 
However, how Nedd4 recognizes its target SLCs in response 
to a specific signal is unknown. Interestingly, mammalian 
arrestin domain–containing (ARRDC) proteins, like their 
yeast counterparts, interact with Nedd4-related ubiquitin 
ligases (Zhang et al., 2010; Rauch and Martin-Serrano, 
2011) and localize to the plasma membrane and/or along the 
endocytic pathway (Oka et al., 2006; Patwari et al., 2009; 
Rauch and Martin-Serrano, 2011; Vina-Vilaseca et al., 2011). 
In agreement with this, ARRDC3 was shown to mediate 
the ubiquitylation and down-regulation of plasma mem-
brane receptors (Draheim et al., 2010; Nabhan et al., 2010). It 
would be interesting to know whether this family of proteins 
Figure 5. Model for the regulation of transporter endo-
cytosis by intracellular signaling through arrestin-related 
protein activation. When yeast cells are grown in lactate 
medium, Snf1, the yeast AMPK homologue, is active and 
phosphorylates Rod1 to inactivate it (red arrows). Glucose 
addition triggers Jen1 endocytosis, which depends on 
Rod1 activation through its PP1-mediated dephosphoryla-
tion and subsequent Rsp5-mediated ubiquitylation, which 
are coordinated by 14-3-3 proteins (green arrows). The 
subcellular compartment at which Rod1 acts on Jen1 endo-
cytosis may be the plasma membrane, or internal com-
partments (dashed lines). See the Discussion for details. 
Noteworthy, the Snf1/PP1 pathway also controls the 
transcriptional reprogramming of cells in response to 
glucose fluctuation, including the expression of the JEN1 
gene (Lodi et al., 2002), illustrating a robust physiological 
regulation in which transcriptional and post-translational 
events are coordinated.
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Spain; Mayordomo et al., 2003) following the same protocol as 
for the coimmunoprecipitations, but using GSH-Sepharose beads 
(GE Healthcare).
GST-WW recombinant protein purification and in vitro GST pull-downs
GST-WW protein was expressed and purified from bacteria using a plas-
mid kindly provided by Dr. Catherine Dargemont (Institut Jacques Monod, 
Paris, France; Gwizdek et al., 2005) and purified in native conditions as 
follows. Bacteria were grown overnight, inoculated at 1/100 in fresh 
medium, and grown for 2 h. Cells were then treated with ethanol (10% 
final concentration) on ice for 10 min, and transferred back at 37°C for 
30 min. After 2 h, protein expression was induced by adding 2.5 mg/ml 
IPTG and cells were grown overnight at 18°C. Bacteria were centrifuged 
and lysed by sonication in 10 ml cold PBS 1x/NaCl 250 mM, supple-
mented with protease inhibitors (Complete, EDTA-free mixture; Roche). 
After centrifugation (18,000 g for 20 min), the lysate was incubated with 
GSH-Sepharose beads for 1 h at 4°C. The beads were resuspended with 
wash buffer (1x PBS, 0.5 M NaCl, 0.1% Triton X-100, and 10% glycerol) 
and then loaded onto a glass Econo-column chromatography column 
(Bio-Rad Laboratories). Beads were then washed with an additional 40 ml 
of wash buffer and recombinant proteins were finally eluted with elution 
buffer (50 mM Tris, pH 8, and 10 mM glutathione). The eluate was dia-
lyzed overnight at 4°C in a dialysis tubing (MWCO 10,000; Carl Roth 
Gmbh) in 1,000 volumes of dialysis buffer (1x PBS, 250 mM NaCl, and 
10% glycerol) to eliminate the glutathione. Proteins were assayed for 
concentration and frozen at 80°C.
GST pull-down experiments were performed using 40 µg of re-
combinant proteins bound to 50 µl GSH-Sepharose beads. Crude extract 
incubations, washes, and elutions were performed as for the immuno-
precipitation experiments.
His6-tagged ubiquitin protein conjugate purification
Cells were transformed with a plasmid expressing 6×Histidine-tagged 
ubiquitin under the control of the copper-inducible CUP1 promoter, kindly 
provided by Dr. Catherine Dargemont. These experiments were performed 
using 100 OD units of cells, grown in exponential phase (A600 = 0.6), 
without addition of extra copper to avoid His6-tagged ubiquitin over-
expression. In this situation, His6-ubiquitin expression level was similar to 
that of endogenous ubiquitin as determined by immunoblotting of crude 
extracts using an anti-ubiquitin antibody (clone P4D1; Santa Cruz Bio-
technology, Inc.). Purification of His6-tagged ubiquitin protein conjugates 
was then performed as described below following a protocol adapted 
from Ziv et al. (2011). Cells were precipitated with TCA to a final concen-
tration of 10% for 30 min on ice, and lysed with glass beads for 20 min at 
4°C. After centrifugation, the pellet was resuspended with 1 ml of gua-
nidium buffer (6 M GuHCl, 20 mM Tris-HCl, pH 8, 100 mM K2HPO4, 10 mM 
imidazole, 100 mM NaCl, and 0.1% Triton X-100) and incubated for 1 h at 
room temperature on a rotating platform. After centrifugation (16,000 g for 
10 min at room temperature), the lysate was incubated for 2.5 h with 
nickel-nitriloacetic acid beads (Ni-NTA superflow; QIAGEN). The beads were 
then washed three times with guanidium buffer, three times with wash buffer 1 
(20 mM Tris-HCl, pH 8.0, 100 mM K2HPO4, 20 mM imidazole, 100 mM 
NaCl, and 0.1% Triton X-100) and three times with wash buffer 2 (20 mM 
Tris-HCl, pH 8.0, 100 mM K2HPO4, 10 mM imidazole, 1 M NaCl, and 0.1% 
Triton X-100). His6-ubiquitin–conjugated proteins were finally eluted with 
40 µl of elution buffer (50 mM Tris-HCl, pH 8.0, and 250 mM imidazole) for 
10 min at room temperature.
Purification of His6-tagged Jen1-GFP
The purification of Jen1-GFP-His6 was performed in denaturing condi-
tions from end3 or art4 end3 cells transformed with pRHT373, en-
coding pGAL:Jen1-GFP-His, using nickel-nitriloacetic acid beads (Ni-NTA 
superflow; QIAGEN). Cells were first grown overnight in SD medium 
containing 2% raffinose and 0.02% glucose to initiate growth. Then, 
galactose was added to a final concentration of 2% for 2 h. Ubiquity-
lation was induced by addition of glucose (2% final concentration) for 
10 min. Cells were harvested and resuspended on ice in 400 µl of cold lysis 
buffer (100 mM Tris-HCl, pH 7.4, 150 mM NaCl, 5 mM EDTA, 10 mM 
N-ethylmaleimide, 1 mM phenylmethylsulfonyl fluoride, and EDTA-free 
protease inhibitor cocktail “Complete” (Roche). Cells were lysed with 
glass beads and the lysate was centrifuged at 1,500 g for 5 min (at 4°C) 
to remove cell debris. The supernatant was further centrifuged for 30 min 
at 13,000 g (at 4°C). The pellet, enriched in plasma membrane proteins, 
was resuspended in 300 µl of buffer “M” (50 mM Tris, pH 7.4, 150 mM 
NaCl, 0.1% SDS, and 1% Triton X-100), and left on ice for 30 min to allow 
for membrane proteins solubilization. Then, TCA was added to a final 
started by adding glucose to a final concentration of 2% (wt/vol) and in-
cubating for the indicated times. For galactose induction of Jen1 in Fig. 3 D, 
cells were directly transferred from an overnight glucose culture to a 
galactose-containing medium due to the slow growth of the snf1 mig1 
mutant in raffinose.
Plasmid constructs
The plasmids used in this paper are described in Table S2. The pROD1 :
ROD1-GFP and the pROD1:ROD1-3HA fusion were amplified from BY4741 
genomic DNA, inserted into pCRII-ZeroBlunt (Invitrogen), and subcloned 
into SacI–XmaI sites in pRS416 (pSL93) and in pRS415 (pSL94), respec-
tively. Site-directed mutageneses were performed by PCR using mutagenic 
oligonucleotides using pSL93 or pSL94 as templates. Mutagenized plas-
mids were checked by sequencing, and a region containing the mutation 
was systematically subcloned into the original pSL93/pSL94 using endog-
enous restriction sites to prevent mutations that may have occurred else-
where on the plasmid. Mutation of the PPxY motifs in PPxA led to pSL118 
and pSL119, respectively. Synthetic constructs from Eurofins-MWG/
Operon (Ebersberg, Germany) were used to construct the lysine mutant 
plasmids (see Fig. S2). The pROD1:ROD1-K0-Nter-3HA (pSL133) was obtained 
from a synthetic construct (lysines 10–367 mutated to arginine; #1 in 
Fig. S2 A) after subcloning into endogenous PacI–BspEI sites in pSL94. 
The pROD1 :ROD1-K0-Cter-3HA (pSL104) construct was obtained from a 
synthetic construct (lysines 401–833 mutated to arginine; #2 in Fig. S2 A) 
after subcloning into endogenous BspEI–XmaI sites in pSL93 and pSL94, 
respectively. The pROD1:ROD1-K0-3HA (pSL134) was obtained by subclon-
ing a PacI–BspEI fragment of pSL133 (C-terminal KR mutant) into PacI–
BspEI sites in pSL104 (N-terminal KR mutant). The pROD1:ROD1-K0-Nter-3HA 
(pSL133) was digested with NsiI–StuI and subcloned at NsiI–StuI sites in 
pSL94, giving rise to pROD1:ROD1-K0-ArrN-3HA (pSL137; #3 in Fig. S2 A). 
The complementary construct was generated by cloning a NsiI–StuI 
fragment of pSL94 into pSL133 at NsiI–StuI sites, giving pROD1:ROD1-
K0-ArrC-3HA (pSL138; #4 in Fig. S2 A). Site-directed mutagenesis was 
performed on pSL138 to mutate three arginines R361, R365, and R367 back 
to lysines to obtain the pROD1:ROD1-K16R-3HA (pSL140). The pROD1:ROD1-
K7R-3HA (pSL143; #5 in Fig. S2 A) and pROD1:ROD1-K9R-3HA (pSL146; 
#6 in Fig. S2 A) constructs were obtained from a synthetic gene after 
subcloning at StuI–BspEI sites in pSL94. The pROD1:ROD1-K(3–9)R-3HA 
(pSL148; #7 in Fig. S2 A) was obtained by subcloning a PacI–NheI frag-
ment from pSL143 into the PacI–NheI sites of pSL146. The pROD1:ROD1-
KR-3HA construct (pSL147; #8 in Fig. S2 A), which contains four lysines 
mutated to arginine, was constructed by subcloning a PacI–NheI fragment 
from pSL146 into the PacI–NheI sites of pSL143. For the yeast two-hybrid, 
plasmids encoding LexA-Rod1 and LexA-Rod1 (394–837) were con-
structed by cloning the corresponding ROD1 coding sequence in pLexA 
(1–202)+PL or pBTM116. Plasmids encoding GAD-Rsp5, GAD-Bmh1 and 
GAD-Reg1 were constructed by cloning the corresponding ORF in the 
polylinker of pACT2 (Takara Bio Inc.).
Total protein extracts, coimmunoprecipitations, and in vivo  
GST pull-downs
For total protein extracts, 1 ml of cells were harvested and precipitated on 
ice for 10 min with trichloroacetic acid (TCA; Sigma-Aldrich) to a final con-
centration of 10%. Cells were lysed with glass beads in a 100-µl volume 
for 10 min at 4°C and the pellet was resuspended in TCA-sample buffer 
(50 mM Tris-HCl, pH 6.8, 100 mM dithiothreitol, 2% SDS, 0.1% bromo-
phenol blue, and 10% glycerol containing 200 mM of unbuffered Tris solu-
tion) at a concentration of 50 µl/initial OD unit, before being denatured at 
37°C for 10 min.
Coimmunoprecipitations were performed using 20–30 OD units of 
cells as described below and in Léon et al. (2008). Cells were resus-
pended in immunoprecipitation (IP) lysis buffer (0.1 M Tris HCl, pH 8, 
0.2 M NaCl, 5% glycerol, 1 mM EDTA, 0.1% Triton X-100, 0.5 mM di-
thiothreitol, 1 mM phenylmethylsulfonyl fluoride, and EDTA-free protease 
inhibitor cocktail “Complete” (Roche) at a concentration of 1 OD unit/10 µl. 
Cells were disrupted with glass beads at 4°C for 10 min. Cell debris and 
unbroken cells were removed by a centrifugation of 5 min at 3,000 g, 
and the supernatant (“Input”) was incubated with GammaBind-Sepharose 
beads previously incubated with the required antibody for 1 h at 4°C. 
The unbound fraction was eliminated by a 10-s centrifugation in a mini-
centrifuge; beads were then washed three times for 10 min (at 4°C) with 
1 ml of IP lysis buffer before elution of the immunoprecipitate with SDS 
sample buffer (1 µl/initial OD).
In vivo GST pull-down experiments were performed using the 
pGST (empty) and pGST-Bmh2 plasmids kindly provided by Dr. Pascual 
Sanz (Consejo Superior de Investigaciones Científicas [CSIC], Valencia, 
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SDS sample buffer. Samples were diluted 1:10 with phosphatase buffer 
and incubated for 2 h at 37°C with or without calf intestinal alkaline phos-
phatase, as recommended by the supplier (Roche). Proteins were then pre-
cipitated again with 10% trichloroacetic acid, resuspended in sample 
buffer, and analyzed by immunoblotting.
The invertase assay was performed as in Vallier and Carlson 
(1994). In brief, glucose-repressed and -derepressed cells were prepared 
from exponentially growing cultures in high glucose (2%) or after shifting 
to low glucose (0.05%) for 2.5 h. Secreted invertase was quantitatively 
assayed by using whole cells washed twice with cold sodium azide at 10 mM. 
Samples (5–50 µl) were incubated with 200 µl 0.1 M sodium acetate, 
pH 5.1, for 20 min at 37°C after the addition of 20 µL of 40% sucrose. 
Glucose standards (2.5–15 µg) were used for calibration. The reaction 
was stopped by boiling the tubes after addition of 200 µl of potassium 
phosphate (200 mM, pH 7.0). 1.0 mL glucose oxidase reagent was 
added, and the tubes were incubated at 37°C for 30 min. The absor-
bance was measured at 540 nm after addition of 1 mL of HCl 6N. Activity 
is expressed as micromoles of glucose released per minute per 100 mg 
(dry weight) of cells.
Online supplemental material
Tables S1 and S2 list yeast strains and plasmids used in this paper, respec-
tively. Fig. S1 describes that Rod1 is the only yeast arrestin-like protein 
involved in the glucose-induced inactivation of lactate transport activity, but 
is not a general regulator of glucose signaling. Fig. S2 shows the mapping 
strategy to identify Rod1 lysines that are targets for ubiquitylation. Fig. S3 
demonstrates that the Snf1/PP1 glucose-signaling pathway regulates the 
glucose-induced endocytosis of Jen1. Online supplemental material is avail-
able at http://www.jcb.org/cgi/content/full/jcb.201109113/DC1.
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concentration of 10% and the sample was incubated on ice for 30 min. 
Precipitated proteins were collected by centrifugation (13,000 g for 
10 min). The pellet was washed briefly in 500 µl of unbuffered Tris solution 
(1 M) to neutralize the sample, and was resuspended with 800 µl of buffer 
“His” (50 mM Tris, pH 7.4, 150 mM NaCl, 1% Triton X-100, and 5 mM 
imidazole). The sample was then centrifuged for 10 min at 13,000 g to 
remove unsolubilized material, and the supernatant was incubated with 
50 µl of prewashed Ni-NTA beads (Ni-NTA superflow; QIAGEN) for 1 h at 
4°C, in rotation. After a brief centrifugation (10 s on a mini-centrifuge), 
the supernatant (unbound fraction) was collected and the beads were 
washed three times with buffer “His”. Elution was performed with 100 µl 
of elution buffer (50 mM Tris, pH 7.4, 150 mM NaCl, 0.5% SDS, 1% 
Triton X-100, and 200 mM imidazole) after a 10-min incubation at 4°C. 
The eluate (8 µl) was loaded on SDS-PAGE gels.
Antibodies and immunoblotting
We used monoclonal antibodies raised against GFP (clones 7.1 and 13.1; 
Roche), actin (clone C4; MP Biomedicals), HA (clone F7; Santa Cruz Bio-
technology, Inc.), anti-ubiquitin antibody coupled to horseradish peroxi-
dase (clone P4D1; Santa Cruz Biotechnology, Inc.), and polyclonal 
antibodies against GFP (a gift from Naima Belgareh, R.H. Tsapis labora-
tory), HA (Y11; Santa Cruz Biotechnology, Inc.), 3-phosphoglycerate 
kinase (PGK; clone 22CS; Invitrogen), GST (Z5; Santa Cruz Biotechnology, 
Inc.), FBPase (a gift from Dr. Carlos Gancedo, CSIC, Madrid, Spain), 
and Bmh2 (a gift from Dr. Sandra Lemmon, University of Miami, Coral 
Gables FL; Gelperin et al., 1995). Images were acquired with the LAS-4000 
imaging system (Fujifilm). Quantification was performed using ImageJ 
(National Institutes of Health) on nonsaturated blots.
Yeast two-hybrid analysis
The two-hybrid screen for LexA-Rod1 (from a pBTM116 derivative; Table 
S1)–interacting proteins was performed in strain TAT7 (Table S2) co-
transformed with a library of S. cerevisiae cDNAs fused to GAD in vector 
pACT (a gift of S. Elledge, Baylor University, Waco, TX). His+ transformants 
(2 × 106 clones) were selected in the presence of 5 mM 3-aminotriazole 
(3-AT) and subsequently screened for -galactosidase activity using a fil-
ter assay. Two-hybrid assays were performed in strain CTY10.5d (Table S2) 
with pLexA (1–202)+PL and pACT2 plasmid derivatives (Table S1). 
-Galactosidase was quantitatively assayed in permeabilized yeast cells 
grown to mid-log phase and expressed in Miller units. Values are aver-
age -galactosidase activities for at least four transformants and stan-
dard errors were <20%.
Fluorescence microscopy
Cells were mounted in medium and observed with a motorized fluores-
cence microscope (model BX-61; Olympus) equipped with a PlanApo-
chromat 100x oil-immersion objective (1.40 NA; Olympus), a Spot 4.05 
charge-coupled device camera, and the MetaVue acquisition software 
(Molecular Devices). Cells were mounted in SD medium and imaged at 
room temperature. GFP-tagged proteins were visualized using a GFP II 
filter (excitation wavelength 440–470 nm; Chroma Technology Corp.). 
Images were processed in ImageJ and Photoshop (Adobe) for levels.
Transport assays
Cells incubated under induction conditions were harvested by centrifuga-
tion and washed twice in ice-cold deionized water to a final concentra-
tion of 25–40 mg dry weight/ml. Conical centrifuge tubes containing 
30 µl of 0.1 M KH2PO4 buffer at pH 5.0 and 10 µl of the yeast suspen-
sion were incubated for 2 min at 25°C. The reaction was started by the 
addition of 10 µl of an aqueous solution of 4,000 d.p.m./nmol of radio-
labeled l-[14C]lactic acid (sodium salt; GE Healthcare) at pH 5.0. The re-
action was stopped by dilution with 5 ml of ice-cold water. The reaction 
mixtures were filtered immediately through GF/C membranes (GE Health-
care) and the filters were washed with 10 ml of ice-cold water and transferred 
to scintillation fluid (Opti-Phase HiSafe II; Pharmacia LKB). Radioactivity was 
measured in a liquid scintillation spectrophotometer (Tri-Carb 2200 CA; 
Packard Instrument Co.) equipped with a d.p.m. correction facility. For 
nonspecific adsorption of 14C, labeled lactic acid was added at time zero 
after the cold water. All the experiments were repeated at least three 
times, and the data reported represent the average values. Representa-
tive experiments of at least three repetitions are presented. The data 
obtained are represented as the mean ± SEM of triplicate measurements.
Other methods
Dephosphorylation of yeast protein extracts was performed on protein ex-
tracts prepared as described above, and proteins were resuspended in 
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